reference/34061935

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34061935

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Research Support, Non-U.S. Gov't
issn	0066-4804 1098-6596
issueIdentifier	5
pageRange	e0139921-
publicationName	Antimicrobial Agents and Chemotherapy
startingPage	e0139921
bibliographicCitation	Gao W, Passarell J, Patel YT, Zhang Z, Lin G, Fiedler-Kelly J, Bruno CJ, Rhee EG, De Anda CS, Feng HP. Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP. Antimicrob Agents Chemother. 2022 May 17;66(5):e0139921. PMID: 35471040; PMCID: PMC9112930.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_546ca09fccef0ab743c4f7fc859aead1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e21c27ca5ddd5dce872804fc51f5dff2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_342a9568606ed006199d22073612d638 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cae8d0b2b34dcf633f9307e1f057ebf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30cbfedb01f990af85436099ad596eee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b13319e693cdab3db81101a4b36d41d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9a1ec422e2af334491133eecec4addc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b095177deedb9e1b79e379469a0009e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5974472f8d17bdd8f33a6b6ca34bd50
date	2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1128/aac.01399-21 https://pubmed.ncbi.nlm.nih.gov/35471040 https://pubmed.ncbi.nlm.nih.gov/PMC9112930
isPartOf	https://portal.issn.org/resource/ISSN/1098-6596 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/686 https://portal.issn.org/resource/ISSN/0066-4804
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Exposure–Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP
discusses	http://id.nlm.nih.gov/mesh/M0127405 http://id.nlm.nih.gov/mesh/M0594225 http://id.nlm.nih.gov/mesh/M0016125 http://id.nlm.nih.gov/mesh/M0003827 http://id.nlm.nih.gov/mesh/M0448397
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D053717Q000188 http://id.nlm.nih.gov/mesh/D018410Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012122 http://id.nlm.nih.gov/mesh/D002511Q000494 http://id.nlm.nih.gov/mesh/D008826 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000900Q000494 http://id.nlm.nih.gov/mesh/D006761 http://id.nlm.nih.gov/mesh/D010397Q000627 http://id.nlm.nih.gov/mesh/D010397Q000494 http://id.nlm.nih.gov/mesh/D000078142Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49863420 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71457955 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10258 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7301c69f4900aeafdbbab7308cdda2b3 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53234134 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID52918380 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123630

Total number of triples: 53.